- Home
- About
- Resource Library
- Mental Health Disorders
- Agitation
- Anxiety Disorders
- Bipolar Disorder
- Cognition
- Depression
- Eating Disorders
- Personality Disorders
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Women’s Health
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Early Episode Psychosis
- Health Care Policy & Legislation
- Neuroscience
- Payer & Financing Models
- Quality Standards & Performance Measures
- Stigma
- Suicide Awareness
- Wellness
- Collections
- Featured
- Monthly Spotlight
- Psychopharmacology
- Learning Tracks
- Community Insights
- Community Podcast
- Disease Management & Support Tools
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Patient & Caregiver Resource Center
- PsychU Roleplay
- Psychiatric Scales
- PsychUSim
- Events
Virtual Event – Antipsychotic Treatment Options in Schizophrenia
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Antipsychotic Treatment Options in Schizophrenia
The treatment of schizophrenia has evolved over the past half-century primarily in the context of antipsychotic drug development. In addition to reviewing the evolution of antipsychotic treatments for schizophrenia, in this virtual live event the speakers will discuss definitions of adherence and review possible reasons for nonadherence, as well as compare evidence supporting oral and long-acting injectable antipsychotics. Lastly, the speakers will explore potential communication strategies for clinicians to assess patient adherence and discuss alternative interventions.
Featuring
-
Martin Guerrero, MD, JD
Forensic and Geriatric Psychiatrist, El Paso, Texas
-
Jessie Chambers, PhD (OPDC)
Senior Clinical & Scientific Liaison
Speaker Martin Guerrero, MD, JD is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc. Speaker Jessie Chambers, PhD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.
Related Events
-
Virtual Event – Monoamine Theory In Depression: Implications For Disease & Treatment
June 3 12:00 pm to 1:00 pm
Registration
Related Resources
-
Chronic Health Care Better For People With SMI In Primary Care Medical Homes With Integrated Psychiatric Care
Article May 16, 2022Among people with serious mental illness (SMI), those who received care through a specialized primary care medical home (PCMH) received more health screenings and had more improvement in care for…
-
May Mental Health Awareness Month: An Interview With Michael Townsend
Interview May 9, 2022May has been recognized and celebrated as Mental Health Awareness month within the United States since 1949. During the month of May, efforts are made to reach millions across the…
-
Hot Topics: Clinical Questions In Schizophrenia (Part 2)
Interview April 15, 2022Dr. Christoph U. Correll will address current and relevant clinical questions relating to schizophrenia. These questions and Dr. Correll’s responses will be recorded and released as short videos every few…
Stay Connected:
- Resource Library